The study identified two endpoints: development of advanced AMD in either eye by participants who did not have this condition at baseline, and advanced AMD in a second eye by participants who, at baseline, had it in one eye.
Variables in the final research model included simple scale score, two genotypes, very large drusen, smoking, family history, advanced AMD in one eye and age of the patient.
Read the Archives of Ophthalmology report on age-related macular degeneration.
Related Articles on Age-Related Macular Degeneration:
Dr. Peter Colquhoun Discusses Four Opportunities for Ophthalmology at Surgery Centers in 2010
Ophthalmologists Consider Anti-VEGF Treatments for AMD Most Significant Advancement of Last Decade
AAO Releases December Ophthalmology Research Highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.